| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002946898 |
| P356 | DOI | 10.1007/S00268-005-0524-9 |
| P698 | PubMed publication ID | 16736327 |
| P50 | author | Luca Viganò | Q79323728 |
| P2093 | author name string | Andrea Muratore | |
| Lorenzo Capussotti | |||
| Alessandro Ferrero | |||
| Roberto Polastri | |||
| Hedayat Bouzari | |||
| P2860 | cites work | Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 |
| Prognosis of hepatocellular carcinoma: the BCLC staging classification | Q29619984 | ||
| Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview | Q33197477 | ||
| Concomitant splenectomy for hypersplenic thrombocytopenia in hepatic resection for hepatocellular carcinoma | Q33329202 | ||
| Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia | Q33362467 | ||
| Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database | Q33362747 | ||
| Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
| An analysis of 412 cases of hepatocellular carcinoma at a Western center | Q34503813 | ||
| Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation | Q34505935 | ||
| Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. | Q34735059 | ||
| The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma | Q35648702 | ||
| Preoperative assessment of liver function | Q35737353 | ||
| Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma | Q43873006 | ||
| No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. | Q52204731 | ||
| Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. | Q53676302 | ||
| Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis | Q68447582 | ||
| The indocyanine green test enables prediction of postoperative complications after hepatic resection | Q69810671 | ||
| Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma | Q72827904 | ||
| Influence of the extent of hepatectomy on the portal hypertensive state in patients with hepatoma | Q73084553 | ||
| Splenectomy in patients with hepatocellular carcinoma and hypersplenism | Q73657742 | ||
| Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors | Q73857009 | ||
| Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years | Q74072065 | ||
| Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths | Q74604755 | ||
| Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes | Q75414924 | ||
| Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade | Q78341860 | ||
| Liver surgery has become simpler | Q78547294 | ||
| Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation | Q79074915 | ||
| One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years | Q79278933 | ||
| P433 | issue | 6 | |
| P921 | main subject | portal hypertension | Q124604 |
| contraindication | Q1848900 | ||
| P304 | page(s) | 992-999 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | World Journal of Surgery | Q15763279 |
| P1476 | title | Portal hypertension: contraindication to liver surgery? | |
| P478 | volume | 30 |
| Q28392783 | 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma |
| Q28394414 | 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma |
| Q64272871 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q91599660 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q33572657 | Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort |
| Q40890148 | Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation |
| Q36429818 | Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients |
| Q88205113 | Distal pancreatectomy with splenorenal shunt to preserve spleen in a cirrhotic patient |
| Q36063323 | Does transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma? |
| Q41931500 | Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure |
| Q37980015 | HCC: current surgical treatment concepts |
| Q36151948 | Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion |
| Q36498498 | Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? |
| Q36009555 | Hepatic resection for hepatocellular carcinoma in patients with portal hypertension: a long-term benefit compared with transarterial chemoembolization and thermal ablation |
| Q34277957 | Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension |
| Q37313977 | Hepatic venous pressure gradient: worth another look? |
| Q42912745 | Hepatocellular carcinoma and cholangiocarcinoma |
| Q35606817 | Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? |
| Q38224434 | Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations |
| Q37285307 | Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy |
| Q89413815 | Impact of clinically significant portal hypertension on surgical outcomes for hepatocellular carcinoma in patients with compensated liver cirrhosis: a propensity score matching analysis |
| Q48187468 | Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients |
| Q50014398 | Indocyanine Green Retention Rates at 15 min Predicted Hepatic Decompensation in a Western Population |
| Q39341703 | Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis |
| Q53658045 | Is it a time to modify the BCLC guidelines in terms of the role of surgery? |
| Q37795703 | Is it time to reconsider the BCLC/AASLD therapeutic flow‐chart? |
| Q42154959 | Liver resection for hepatocellular carcinoma in patients with portal hypertension: the role of laparoscopy |
| Q38088585 | Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension |
| Q41333815 | Multiple Tumors Located in the Same Section Are Associated with Better Outcomes After Hepatic Resection for HCC Patients Meeting the Milan Criteria |
| Q38060642 | New paradigms in post-hepatectomy liver failure |
| Q37542835 | Novel implications in the treatment of hepatocellular carcinoma |
| Q90749815 | Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics |
| Q38248394 | Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. |
| Q39898473 | Predicting Individual Survival After Hepatectomy for Hepatocellular Carcinoma: a Novel Nomogram from the "HCC East & West Study Group". |
| Q30432108 | Pretreatment assessment of hepatocellular carcinoma: expert consensus statement |
| Q33769497 | Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People's Republic of China |
| Q50478825 | Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. |
| Q53272100 | Recent advances in diagnosis of portal hypertension |
| Q50540534 | Relationship of Hepatic Functional Parameters with Changes of Functional Liver Volume Using Technetium-99m Galactosyl Serum Albumin Scintigraphy in Patients Undergoing Preoperative Portal Vein Embolization: A Follow-Up Report |
| Q89413813 | Risk factors of postoperative ascites on hepatic resection for hepatocellular carcinoma |
| Q35970181 | Safety validation of decision trees for hepatocellular carcinoma |
| Q50213281 | Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices |
| Q42129616 | Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report. |
| Q81795140 | Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? |
| Q50448705 | Surgical resection for hepatocellular carcinoma: Moving from what can be done to what is worth doing |
| Q27690723 | Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique |
| Q64885102 | Surgical treatment of hepatocellular carcinoma: should resection be performed according to Barcelona Clinic Liver Cancer classification? |
| Q35441132 | The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis |
| Q43752461 | The role of hepatic resection in the treatment of hepatocellular cancer |
Search more.